Advertisement
Advertisement

LIXT

LIXT logo

Lixte Biotechnology Holdings, Inc. Common Stock

4.95
USD
+0.12
+2.38%
Aug 11, 15:23 UTC -4
Open

Lixte Biotechnology Holdings, Inc. Common Stock Profile

About

Lixte Biotechnology Holdings Inc. is a drug discovery company which uses biomarker technology to identify enzyme targets associated with serious common diseases. The company's product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers. Lixte Biotechnology Holdings Inc. is based in NY.

Info & Links

CEO

John S. Kovach

Headquarters

680 EAST COLORADO BOULEVARD,SUITE 180
PASADENA, CA 91101, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.lixte.com

Auditor

Weinberg & Company, P.A.

Share holders

35

Employees

2

Lixte Biotechnology Holdings, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

14.97M

Enterprise Value

14.08M

Enterprise Value/EBITDA(ttm)

-4.57

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-253.03%

Return on Assets(ttm)

-189.35%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-3.08M

Net Income Available to Common(ttm)

-3.09M

Diluted EPS(ttm)

-1.45

Share Statistics

Beta (5Y Monthly)

0.31

52-Week Change

126.72%

S&P 500 52-Week Change

19.42%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

4.56M

Dividend Yield

0.00%

Float4

2.29M

% Held by Insiders

14.80%

% Held by Institutions

5.10%

Balance Sheet

Total Cash(mrq)

887.20K

Total Cash Per Share(mrq)

0.19

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.26%

Quick Ratio(mrq)

4.26%

Book Value Per Share(mrq)

0.43

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.23

Free Cash Flow(ytd)

-568.50K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement